Perceptive Advisors ADGM Position
Active3-Fund ConvergencePerceptive Advisors held their position in Adagio Medical Holdings, Inc. (ADGM) in Q4 2025, holding $10.3M worth of shares across 9,876,576 shares.
The position was first reported in Q3 2024 and has been tracked across 6 quarterly 13F filings.
ADGM is a convergence signal: 3 specialist biotech funds hold this stock, suggesting high institutional conviction.
About Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Full company profile →Short Interest
0.2%
0.4 days to cover
Perceptive Advisors ADGM Position History
Frequently Asked Questions
Does Perceptive Advisors own ADGM?
Yes. As of Q4 2025, Perceptive Advisors holds 9,876,576 shares of Adagio Medical Holdings, Inc. (ADGM) valued at $10.3M. This data comes from their SEC 13F filing.
How many hedge funds own ADGM?
3 specialist biotech hedge funds currently hold ADGM, including RA Capital Management, RTW Investments. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy ADGM?
Perceptive Advisors's position in ADGM was first reported in Q3 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's ADGM position increasing or decreasing?
Perceptive Advisors held their ADGM position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
ADGMCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →